ACADIA Pharmaceuticals Inc. vs Apartment Investment and Management Co — how do they compare? ACADIA Pharmaceuticals Inc. trades at $29.52 (market cap $5.07B), while Apartment Investment and Management Co trades at $2.61 (market cap $376.16M). The key difference: ACADIA Pharmaceuticals Inc. is far larger — about 13.5× Apartment Investment and Management Co's market cap, and ACADIA Pharmaceuticals Inc. is trading nearer its 52-week high, Apartment Investment and Management Co nearer its low. Which is the better fit depends on your goals.
| ACAD | AIV | |
|---|---|---|
Market Cap | $5.07B | $376.16M |
Sector | Health | Real Estate |
52-Week High | $29.41 | $7.93 |
52-Week Low | $20.06 | $2.59 |
Enterprise Value | $4.19B | $738.32M |
Trailing returns across standard periods
Latest headlines on both assets
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Read more on ACAD →Apartment Investment & Management Co is a self-managed real estate investment trust. It is focused on property development, redevelopment and various other value-creating investment strategies, targeting the U.S multifamily market. Its operating segments are Development and Redevelopment
Read more on AIV →